206 related articles for article (PubMed ID: 33842362)
1. Novel Patient Metastatic Pleural Effusion-Derived Xenograft Model of Renal Medullary Carcinoma Demonstrates Therapeutic Efficacy of Sunitinib.
Lee AQ; Ijiri M; Rodriguez R; Gandour-Edwards R; Lee J; Tepper CG; Li Y; Beckett L; Lam K; Goodwin N; Satake N
Front Oncol; 2021; 11():648097. PubMed ID: 33842362
[TBL] [Abstract][Full Text] [Related]
2. Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
Karalis JD; Yoon LY; Hammer STG; Hong C; Zhu M; Nassour I; Ju MR; Xiao S; Castro-Dubon EC; Agrawal D; Suarez J; Reznik SI; Mansour JC; Polanco PM; Yopp AC; Zeh HJ; Hwang TH; Zhu H; Porembka MR; Wang SC
J Transl Med; 2022 Mar; 20(1):116. PubMed ID: 35255940
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.
Oda Y; Niimi K; Yoshida K; Tamauchi S; Yokoi A; Yasui Y; Nishiko Y; Shibata M; Shimizu Y; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Yamamoto E; Kajiyama H
BMC Cancer; 2023 Nov; 23(1):1103. PubMed ID: 37957624
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a patient-derived xenograft model and cell line of malignant transformation of mature cystic teratoma of the ovary.
Tamauchi S; Suzuki S; Xuboya C; Yoshihara M; Yoshida K; Ikeda Y; Yoshikawa N; Kajiyama H; Kikkawa F
J Obstet Gynaecol Res; 2021 Feb; 47(2):713-719. PubMed ID: 33300248
[TBL] [Abstract][Full Text] [Related]
5. Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early Experience.
Nishie R; Tanaka T; Hirosuna K; Miyamoto S; Murakami H; Tsuchihashi H; Toji A; Ueda S; Morita N; Hashida S; Daimon A; Terada S; Maruoka H; Konishi H; Kogata Y; Taniguchi K; Komura K; Ohmichi M
J Clin Med; 2024 May; 13(9):. PubMed ID: 38731247
[No Abstract] [Full Text] [Related]
6. An autologous humanized patient-derived xenograft (PDX) model for evaluation of nivolumab immunotherapy in renal cell cancer: a case report.
Kang Y; Armstrong AJ; Hsu DS
Stem Cell Investig; 2022; 9():8. PubMed ID: 36393918
[TBL] [Abstract][Full Text] [Related]
7. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
8. Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers.
Peng S; Creighton CJ; Zhang Y; Sen B; Mazumdar T; Myers JN; Lai SY; Woolfson A; Lorenzi MV; Bell D; Williams MD; Johnson FM
J Transl Med; 2013 Aug; 11():198. PubMed ID: 23981300
[TBL] [Abstract][Full Text] [Related]
9. Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma.
Wu L; Allo G; John T; Li M; Tagawa T; Opitz I; Anraku M; Yun Z; Pintilie M; Pitcher B; Liu G; Feld R; Johnston MR; de Perrot M; Tsao MS
Clin Cancer Res; 2017 Feb; 23(4):1060-1067. PubMed ID: 27683181
[No Abstract] [Full Text] [Related]
10. Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy.
Shapiro DD; Zacharias NM; Tripathi DN; Karki M; Bertocchio JP; Soeung M; He R; Westerman ME; Gao J; Rao P; Lam TNA; Jonasch E; Perelli L; Cheng EH; Carugo A; Heffernan TP; Walker CL; Genovese G; Tannir NM; Karam JA; Msaouel P
Clin Transl Med; 2023 May; 13(5):e1267. PubMed ID: 37226898
[TBL] [Abstract][Full Text] [Related]
11. Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer.
Pu X; Zhang R; Wang L; Chen Y; Xu Y; Pataer A; Meraz IM; Zhang X; Wu S; Wu L; Su D; Mao W; Heymach JV; Roth JA; Swisher SG; Fang B
J Transl Med; 2018 Nov; 16(1):328. PubMed ID: 30477533
[TBL] [Abstract][Full Text] [Related]
12. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
Owonikoko TK; Zhang G; Kim HS; Stinson RM; Bechara R; Zhang C; Chen Z; Saba NF; Pakkala S; Pillai R; Deng X; Sun SY; Rossi MR; Sica GL; Ramalingam SS; Khuri FR
J Transl Med; 2016 May; 14(1):111. PubMed ID: 27142472
[TBL] [Abstract][Full Text] [Related]
14. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of patient-derived head and neck cancer models from surgical specimens and endoscopic biopsies.
Strüder D; Momper T; Irmscher N; Krause M; Liese J; Schraven S; Zimpfer A; Zonnur S; Burmeister AS; Schneider B; Frerich B; Mlynski R; Große-Thie C; Junghanss C; Maletzki C
J Exp Clin Cancer Res; 2021 Aug; 40(1):246. PubMed ID: 34362423
[TBL] [Abstract][Full Text] [Related]
16. Establishment of pancreatic cancer patient-derived xenograft models and comparison of the differences among the generations.
Xu W; Yang XW; Zhao ZY; Dong B; Guan XY; Tian XY; Qian HG; Hao CY
Am J Transl Res; 2019; 11(5):3128-3139. PubMed ID: 31217882
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a Patient-Derived Tumor Xenograft Model and Application for Precision Cancer Medicine.
Okada S; Vaeteewoottacharn K; Kariya R
Chem Pharm Bull (Tokyo); 2018; 66(3):225-230. PubMed ID: 29491256
[TBL] [Abstract][Full Text] [Related]
18. Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration.
Fuchs V; Sobarzo A; Msamra M; Kezerle Y; Linde L; Sevillya G; Anoze A; Refaely Y; Cohen AY; Melamed I; Azriel A; Shoukrun R; Raviv Y; Porgador A; Peled N; Roisman LC
Clin Transl Oncol; 2024 Mar; ():. PubMed ID: 38553659
[TBL] [Abstract][Full Text] [Related]
19. Establishment and preclinical application of a patient-derived xenograft model for uterine cancer.
Jeong SY; Cho YJ; Ryu JY; Choi JJ; Hwang JR; Kim B; Lee YY; Kim HS; Lee JW
Gynecol Oncol; 2021 Jul; 162(1):173-181. PubMed ID: 33972086
[TBL] [Abstract][Full Text] [Related]
20. Defining the boundaries and expanding the utility of head and neck cancer patient derived xenografts.
Swick AD; Stein AP; McCulloch TM; Hartig GK; Ong IM; Sampene E; Prabakaran PJ; Liu CZ; Kimple RJ
Oral Oncol; 2017 Jan; 64():65-72. PubMed ID: 28024726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
